{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By DAVID GELLES", "person": [{"rank": 1, "role": "reported", "firstname": "David", "organization": "", "lastname": "GELLES"}]}, "abstract": "Israeli generic drug manufacturer Teva makes unsolicited $40 billion offer for Dutch rival Mylan, whose $29 billion bid to acquire Irish drug maker Perrigo is rejected hours later; feverish deal-making comes amid frenzied consolidation that is reshaping the global pharmaceutical industry.", "type_of_material": "News", "word_count": "1045", "lead_paragraph": "The unsolicited offer of $82 a share would scuttle Mylan&#8217;s proposed acquisition of Perrigo in a shake-up of the generic drug industry.", "pub_date": "2015-04-22T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Teva, Maker of Generic Drugs, Bids $40 Billion to Acquire Its Rival Mylan", "print_headline": "Teva Bids $40 Billion to Acquire a Rival"}, "snippet": "The unsolicited offer of $82 a share would scuttle Mylan&#8217;s proposed acquisition of Perrigo in a shake-up of the generic drug industry.", "multimedia": [{"height": 126, "url": "images/2015/04/22/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/04/22/business/db-drug-web1/db-drug-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 399, "url": "images/2015/04/22/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "399", "xlarge": "images/2015/04/22/business/db-drug-web1/db-drug-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/04/22/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/04/22/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/04/22/business/dealbook/teva-offers-to-acquire-mylan-for-40-billion.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Mylan Inc", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Perrigo Company", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}], "blog": [], "_id": "553652ce38f0d821acced005", "source": "The New York Times"}